Bb Biotech as of Dec. 31, 2013
Portfolio Holdings for Bb Biotech
Bb Biotech holds 23 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 18.3 | $343M | 2.0M | 168.97 | |
| Gilead Sciences (GILD) | 14.2 | $266M | 3.5M | 75.10 | |
| ISIS Pharmaceuticals | 13.7 | $256M | 6.4M | 39.84 | |
| Incyte Corporation (INCY) | 11.4 | $214M | 4.2M | 50.63 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.6 | $104M | 1.4M | 74.30 | |
| Alexion Pharmaceuticals | 5.4 | $101M | 757k | 132.88 | |
| Medivation | 5.0 | $94M | 1.5M | 63.82 | |
| Halozyme Therapeutics (HALO) | 3.8 | $71M | 4.7M | 14.99 | |
| Pharmacyclics | 3.6 | $67M | 637k | 105.78 | |
| Synageva Biopharma | 3.0 | $56M | 859k | 64.72 | |
| Regeneron Pharmaceuticals (REGN) | 2.8 | $53M | 192k | 275.24 | |
| ImmunoGen | 2.5 | $47M | 3.2M | 14.67 | |
| Theravance | 1.7 | $32M | 888k | 35.65 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $30M | 471k | 64.30 | |
| Clovis Oncology | 1.6 | $29M | 488k | 60.27 | |
| Endocyte | 1.5 | $28M | 2.6M | 10.68 | |
| Neurocrine Biosciences (NBIX) | 1.3 | $25M | 2.6M | 9.34 | |
| Infinity Pharmaceuticals (INFIQ) | 1.0 | $18M | 1.3M | 13.81 | |
| Tesaro | 0.7 | $13M | 471k | 28.24 | |
| Ariad Pharmaceuticals | 0.5 | $9.5M | 1.4M | 6.82 | |
| Idenix Pharmaceuticals | 0.4 | $7.5M | 1.3M | 5.98 | |
| Achillion Pharmaceuticals | 0.3 | $5.9M | 1.8M | 3.32 | |
| Cubist Pharmaceutic-cvr | 0.1 | $1.2M | 876k | 1.35 |
